An epidemiological, prospective cohort study for patients with HR+/HER2- advanced breast cancer treated 1st-line with an endocrine-based palbociclib combination therapy in real world in Germany and Austria 21. Mai 2021 Lux, M. P., Resch, T., Fuxius, S., Gabrysiak, T., Amann, E., Buncke, J., Frank, M., Runkel, E. D., Thill, M., 2021. Download Rare lymphomas in routine practice – Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms Knauf, W., Abenhardt, W., Koenigsmann, M., Maintz, C., Sandner, R., Zahn, M.-O., Schnell, R., Tech, S., Kaiser-Osterhues, A., Houet, L., Marschner, N., the TLN-Group (Tumour… Weiterlesen Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients Metz, M., Semsek, D., Rogmans, G., Hutzschenreuter, U., Fietz, T., Harde, J., Zacharias, S., Hielscher, C., Lorenz, A., Zahn, M.-O., Guth, D., Liebers, S., Berghorn,… Weiterlesen